Quantum Computing for Drug Design: Where Quantum Meets Chemistry

A new white paper from SC Quantum and qBraid explores the path forward for quantum computing in drug design

(SQ Quantum is an IYQ Leading Philanthropic Partner.)

Designing effective drugs is one of the most complex and costly challenges in modern science. It can take more than a decade to move a single treatment from concept to clinic. Today, researchers and pharmaceutical leaders are exploring how quantum computing might offer a better way forward.

In this white paper, developed in collaboration with qBraid, we explore the intersection of quantum computing and drug design. From foundational science to real-world use cases, the paper offers a grounded look at what’s happening, what’s possible, and what still lies ahead.

Beyond the Hype: What Quantum Can and Can’t Do

The promise of quantum computing has been part of the drug discovery conversation for years. Until recently, much of that promise remained theoretical. That’s now changing. New advances in quantum hardware and algorithms are opening doors to better understand complex molecules, simulate protein interactions, and speed up key phases of the drug pipeline.

At the same time, there are real challenges to overcome, such as limited qubit counts, noise, modeling scale, and the fundamental complexity of biological systems. The paper presents these limitations with clarity, helping readers separate marketing from milestones.

A Use Case with Real Impact

To show this work in practice, the white paper highlights a research pipeline from qBraid focused on Alzheimer’s disease. Partnering with institutions like MIT, Argonne National Lab, and North Carolina A&T, qBraid is using quantum techniques to study protein-metal interactions tied to neurodegeneration. Their Quanta-Bind platform is one example of how researchers are applying quantum tools to real-world problems.

South Carolina’s Role in What’s Next

Pharmaceutical companies across South Carolina are well-positioned to explore these technologies, from small-molecule research to clinical applications. The white paper identifies companies already doing groundbreaking work in diagnostics, therapeutics, and delivery systems. With quantum computing now reaching a more practical stage, the timing is right to explore how these tools could support R&D pipelines across the region.

Get the White Paper

This is the first in a series from SC Quantum and qBraid spotlighting how quantum technologies are taking shape in real-world industries. It’s designed for decision-makers, technical leads, and anyone interested in what the future of quantum might actually look like.

📄 Click here to download the white paper.

---

Dave Alsobrooks is Director of Communications, SC Quantum

Featured image: Dave Alsobrooks.